Eton Pharmaceuticals Inc. (ETON) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Eton Pharmaceuticals Inc.

    NASDAQ: ETON · Real-Time Price · USD
    17.67
    -0.20 (-1.12%)
    At close: Sep 05, 2025, 3:59 PM
    17.67
    0.00%
    After-hours: Sep 05, 2025, 04:42 PM EDT

    Eton Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 39.01M 31.64M 21.25M 21.83M
    Cost of Revenue
    		 15.6M 10.58M 6.93M 2.62M
    Gross Profit
    		 23.41M 21.06M 14.32M 19.21M
    Operating Income
    		 -2.6M -1.19M -8.26M -1.5M
    Interest Income
    		 n/a n/a 761K 1.01M
    Pretax Income
    		 -3.81M -689K -9.02M -1.96M
    Net Income
    		 -3.82M -936K -9.02M -1.96M
    Selling & General & Admin
    		 22.75M 18.93M 18.58M 14.47M
    Research & Development
    		 3.25M 3.32M 4M 6.24M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 26.01M 22.25M 22.58M 20.7M
    Interest Expense
    		 2M 1.06M 955K 1.01M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 41.61M 32.83M 29.51M 23.33M
    Income Tax Expense
    		 15K 247K 761K 1.01M
    Shares Outstanding (Basic)
    		 25.89M 25.64M 25.15M 25.21M
    Shares Outstanding (Diluted)
    		 25.89M 25.65M 25.15M 25.21M
    EPS (Basic)
    		 -0.15 -0.04 -0.36 -0.08
    EPS (Diluted)
    		 -0.15 -0.04 -0.36 -0.08
    EBITDA
    		 -1.45M -291K -6.49M -1.12M
    EBIT
    		 -2.6M -1.19M -8.26M -1.5M
    Depreciation & Amortization
    		 1.15M 901K 1.76M 374K

    Add to Watchlist